Australia markets open in 9 hours 28 minutes

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
76.60-1.14 (-1.47%)
As of 10:32AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 167.56B
Enterprise value 198.36B
Trailing P/E 27.91
Forward P/E 10.33
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.72
Price/book (mrq)5.31
Enterprise value/revenue 4.22
Enterprise value/EBITDA 10.35

Trading information

Stock price history

Beta (5Y monthly) 0.48
52-week change 317.61%
S&P500 52-week change 3-11.60%
52-week high 380.59
52-week low 353.22
50-day moving average 376.17
200-day moving average 366.75

Share statistics

Avg vol (3-month) 314.74M
Avg vol (10-day) 314.25M
Shares outstanding 52.13B
Implied shares outstanding 6N/A
Float 82.13B
% held by insiders 10.08%
% held by institutions 179.26%
Shares short (30 May 2022) 433.04M
Short ratio (30 May 2022) 42.09
Short % of float (30 May 2022) 41.55%
Short % of shares outstanding (30 May 2022) 41.55%
Shares short (prior month 28 Apr 2022) 435.37M

Dividends & splits

Forward annual dividend rate 42.16
Forward annual dividend yield 42.93%
Trailing annual dividend rate 32.06
Trailing annual dividend yield 32.65%
5-year average dividend yield 42.94
Payout ratio 473.05%
Dividend date 331 July 2022
Ex-dividend date 429 June 2022
Last split factor 21000000:951777
Last split date 306 Aug 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 13.31%
Operating margin (ttm)22.19%

Management effectiveness

Return on assets (ttm)6.05%
Return on equity (ttm)18.08%

Income statement

Revenue (ttm)46.96B
Revenue per share (ttm)21.36
Quarterly revenue growth (yoy)5.20%
Gross profit (ttm)37.05B
EBITDA 21.09B
Net income avi to common (ttm)6.25B
Diluted EPS (ttm)2.82
Quarterly earnings growth (yoy)-36.80%

Balance sheet

Total cash (mrq)15.2B
Total cash per share (mrq)7.14
Total debt (mrq)45.99B
Total debt/equity (mrq)145.35
Current ratio (mrq)1.32
Book value per share (mrq)14.83

Cash flow statement

Operating cash flow (ttm)16.2B
Levered free cash flow (ttm)14.87B